Business Description
Pharmigene Inc
ISIN : TW0007595B13
Share Class Description:
ROCO:7595: Ordinary SharesDescription
Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 1.54 | |||||
| Debt-to-EBITDA | -10.77 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.61 | |||||
| Beneish M-Score | -2.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.9 | |||||
| 3-Year EPS without NRI Growth Rate | -72.8 | |||||
| 3-Year FCF Growth Rate | -194 | |||||
| 3-Year Book Growth Rate | -2.3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.68 | |||||
| 9-Day RSI | 40.81 | |||||
| 14-Day RSI | 39.07 | |||||
| 6-1 Month Momentum % | -15.66 | |||||
| 12-1 Month Momentum % | -31.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.13 | |||||
| Quick Ratio | 5.24 | |||||
| Cash Ratio | 4.05 | |||||
| Days Inventory | 119.83 | |||||
| Days Sales Outstanding | 54.17 | |||||
| Days Payable | 28.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.1 | |||||
| Shareholder Yield % | -44.27 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.12 | |||||
| Operating Margin % | -58.83 | |||||
| Net Margin % | -72.92 | |||||
| FCF Margin % | -112.67 | |||||
| ROE % | -23.93 | |||||
| ROA % | -9.3 | |||||
| ROIC % | -8.89 | |||||
| ROC (Joel Greenblatt) % | -12.36 | |||||
| ROCE % | -8.41 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.07 | |||||
| PB Ratio | 1.76 | |||||
| Price-to-Tangible-Book | 1.83 | |||||
| EV-to-EBIT | -14.25 | |||||
| EV-to-EBITDA | -20.47 | |||||
| EV-to-Revenue | 8.99 | |||||
| EV-to-FCF | -7.86 | |||||
| Earnings Yield (Greenblatt) % | -7.02 | |||||
| FCF Yield % | -20.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmigene Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 127.083 | ||
| EPS (TTM) (NT$) | -1.91 | ||
| Beta | -0.39 | ||
| Volatility % | 17.22 | ||
| 14-Day RSI | 39.07 | ||
| 14-Day ATR (NT$) | 0.521168 | ||
| 20-Day SMA (NT$) | 14.0375 | ||
| 12-1 Month Momentum % | -31.37 | ||
| 52-Week Range (NT$) | 12.5 - 21.1 | ||
| Shares Outstanding (Mil) | 50.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmigene Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmigene Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmigene Inc Frequently Asked Questions
What is Pharmigene Inc(ROCO:7595)'s stock price today?
The current price of ROCO:7595 is NT$13.65. The 52 week high of ROCO:7595 is NT$21.10 and 52 week low is NT$12.50.
When is next earnings date of Pharmigene Inc(ROCO:7595)?
The next earnings date of Pharmigene Inc(ROCO:7595) is .
Does Pharmigene Inc(ROCO:7595) pay dividends? If so, how much?
Pharmigene Inc(ROCO:7595) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers